Research at the Institute of Biomedicine is divided into three functional units: 1) Infection and Immunity, 2) Integrative Physiology and Pharmacology and 3) Cancer research. Research at our Institute includes both biomedical basic research and translational research, and the unit division expresses our research priorities.
We encourage creative interdisciplinary combination of research topics via collaboration of the individual research groups and the three units. In addition, we collaborate locally with clinical researchers, with other institutes of our university and with the Åbo Akademi University. We are also widely networked with numerous national and international universities and public and private research institutes.
Research services
Recent publications
Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. (2008)
International Journal of Andrology
(Refereed journal article or data article (A1))
Novel expression and direct effects of adiponectin in the rat testis (2008)
Endocrinology
(Refereed journal article or data article (A1))
Borrelia burgdorferi inhibits human neutrophil functions (2008)
Microbes and Infection
(Refereed journal article or data article (A1))
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones (2008)
Virology
(Refereed journal article or data article (A1))
Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer. (2008)
British Journal of Cancer
(Refereed journal article or data article (A1))
Recent doctoral dissertations
Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. (2008)
International Journal of Andrology
(Refereed journal article or data article (A1))
Novel expression and direct effects of adiponectin in the rat testis (2008)
Endocrinology
(Refereed journal article or data article (A1))
Borrelia burgdorferi inhibits human neutrophil functions (2008)
Microbes and Infection
(Refereed journal article or data article (A1))
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones (2008)
Virology
(Refereed journal article or data article (A1))
Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer. (2008)
British Journal of Cancer
(Refereed journal article or data article (A1))